Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares for the month of June 2025. The filing details a share repurchase executed on June 19, 2025, pursuant to a non-discretionary agreement with Merrill Lynch International entered into on June 4, 2025.
Key Financial Metrics and Transaction Details
The filing focuses exclusively on capital structure changes via share buybacks. It does not contain revenue, profit, cash flow, margin, or debt metrics.
- Shares Purchased (June 19, 2025): 473,254 ordinary shares.
- Price Range: Lowest 1,424.00p; Highest 1,441.50p.
- Volume-Weighted Average Price (VWAP): 1,434.72p.
- Cumulative Purchases (Since June 4, 2025): 4,664,836 ordinary shares.
- Treasury Shares Held: 222,799,219 ordinary shares.
- Shares in Issue (Excluding Treasury): 4,092,502,370 ordinary shares.
- Voting Rights in Treasury: 5.44% of total voting rights.
Material Changes
The primary material change is the reduction of shares in issue and the increase in treasury shares held by the Company. Following the June 19 transaction, the Company's treasury holding represents 5.44% of the total voting rights. The filing notes that the total number of voting rights is 4,092,502,370, which serves as the denominator for shareholder notification calculations under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. The transaction was executed under a pre-existing non-discretionary agreement, indicating a routine execution of the Company's capital return strategy rather than a discretionary market intervention.
Investor Verification Checklist
- Verify the total remaining authorization under the Company's existing buyback programme.
- Confirm the impact of the 5.44% treasury holding on earnings per share (EPS) calculations.
- Review the June 4, 2025 announcement for the total scope and duration of the non-discretionary agreement with Merrill Lynch International.
- Check subsequent filings for further repurchase activity under the same programme.